EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML

Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, Ines Bergerweiss, Karolin Stumpf, Barbara Betz, Susanna Gabrowski, Frank Y Huang, Maria-Eleni Lalioti, Bendix Hempel, Markus Sohn, Heikki Kuusanmäki und 18 weitere

Cell Stem Cell · 2026-06 · 33 (6) · 982-999.e8

DOI: 10.1016/j.stem.2026.04.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2026-06. Verfasst von Alexander Waclawiczek und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany; Heidelberg Institute for Stem Ce…. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Leukemia, Myeloid, Acute, Neoplastic Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Horizon Europe, Bundesministerium für Forschung, Technologie und Raumfahrt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bridged Bicyclo Compounds, HeterocyclicSulfonamidesLeukemia, Myeloid, AcuteNeoplastic Stem CellsDrug Resistance, NeoplasmHumansAnimalsProto-Oncogene Proteins c-bcl-2

Stichwörter der Autor:innen

BCL-2MAC-scoreacute myeloid leukemiaazacitidinechemotherapyleukemic stem cellspersonalized medicineplasticitytherapy resistancevenetoclax

Substanzen

venetoclaxBridged Bicyclo Compounds, HeterocyclicSulfonamidesProto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, G…
  • Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • German Cancer Consortium (DKTK), Heidelberg, Germany.

Förderung

  • European Research Council
  • Horizon Europe
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • German Cancer Aid
  • Horizon 2020 Framework Programme
  • EMBO
  • Joachim Herz Stiftung
  • Deutsches Krebsforschungszentrum

Zitieren

APA

Waclawiczek, A., Leppä, A. M., Renders, S., Bergerweiss, I., Stumpf, K., Betz, B., Gabrowski, S., Huang, F. Y., Lalioti, M. E., Hempel, B., Sohn, M., Kuusanmäki, H., Thiel, V., Unglaub, J. M., Shahswar, R., Richter, S., Janssen, M., Karpova, D., Donato, E., …, & Trumpp, A. (2026). Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML. Cell Stem Cell, 33(6), 982-999.e8. https://doi.org/10.1016/j.stem.2026.04.012

Vancouver

Waclawiczek A, Leppä AM, Renders S, Bergerweiss I, Stumpf K, Betz B, et al. Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML. Cell Stem Cell. 2026;33(6):982-999.e8. doi:10.1016/j.stem.2026.04.012

BibTeX
@article{Waclawiczek2026,
  author = {Waclawiczek, Alexander and Leppä, Aino-Maija and Renders, Simon and Bergerweiss, Ines and Stumpf, Karolin and Betz, Barbara and Gabrowski, Susanna and Huang, Frank Y and Lalioti, Maria-Eleni and Hempel, Bendix and Sohn, Markus and Kuusanmäki, Heikki and Thiel, Vera and Unglaub, Julia M and Shahswar, Rabia and Richter, Sarah and Janssen, Maike and Karpova, Darja and Donato, Elisa and Bonig, Halvard and Röllig, Christoph and Raffel, Simon and Heuser, Michael and Hundemer, Michael and Kontro, Mika and Eisfeld, Ann-Kathrin and Sauer, Tim and Cabezas-Wallscheid, Nina and Müller-Tidow, Carsten and Trumpp, Andreas},
  title = {Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML},
  journal = {Cell Stem Cell},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {982--999.e8},
  doi = {10.1016/j.stem.2026.04.012}
}
Kostenlos starten →